Clinical Trial Update: Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluated the combination of topotecan, paclitaxel, and carboplatin as initial treatment for advanced ovarian cancer and primary perito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Ovary Cancer | Phase 2 | Status: COMPLETED